August 06, 2021 1:30 pm
Glenmark Life Sciences, a subsidiary of Glenmark Pharmaceuticals, is a leading developer and manufacturer of select high-value, non-commoditised Active Pharmaceutical Ingredients (APIs) in chronic therapeutic areas.
August 03, 2021 9:28 pm
Glenmark Life Sciences IPO allotment status: Initial public offering (IPO) of Glenmark Life Sciences, the wholly-owned subsidiary of Glenmark Pharmaceuticals, was subscribed 44.17 times and the shares will now get allotted to investors. Here's how to check if you have been allotted the shares.
July 30, 2021 9:45 am
Glenmark Life Sciences IPO subscription status: Glenmark Life Sciences IPO was subscribed 44.17 times on the final day of the offer.
June 22, 2020 1:25 pm
The scrip jumped 19.99 per cent to Rs 490.90 -- its upper circuit limit -- on the BSE. On the NSE, it zoomed 19.99 per cent to Rs 491.20 -- its highest permissible trading limit for the day.
April 30, 2020 2:03 pm
The Mumbai-based company is the first pharmaceutical company in India to be given an approval by the regulator to start the trial on COVID-19 patients in the country.
May 16, 2015 2:15 am
SC restrained Glenmark Pharmaceuticals from the manufacture and sales of anti-diabetes drug, Sitagliptin.
March 21, 2015 1:39 am
The court of Justice S Ravindra Bhat and Justice Najmi Waziri issued the injunction, directing Glenmark to stop supply of the drugs.
April 21, 2014 9:34 am
December 06, 2013 3:12 pm
Sensex has been fuelled almost exclusively by TCS & Sun Pharma,which are up close to 60% this year.
November 25, 2013 3:00 am
One in four abbreviated new drug applications approved by regulator in 2012 belonged to Indian company.